Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering

Portage, Mich., USA, Aug. 31, 2026 (GLOBE NEWSWIRE) —

Stryker (NYSE:SYK), a global leader in medical technologies, announced it has signed a definitive agreement to acquire ZuriMED, a privately held company and developer of the FiberLocker® System. This commercialized technology provides a novel approach for rotator cuff augmentation with increased biomechanical strength to address a key clinical failure mode in rotator cuff repair.

Gold-Standard Cochrane Review Confirms: Nicotine Vaping Helps More Smokers Quit Than Traditional Nicotine Replacement Therapy

The Canadian Vaping Association calls on Health Canada to align with the world’s most rigorous scientific evidence and better inform smokers that vaping is a less harmful alternative that can help them quit

The Canadian Vaping Association calls on Health Canada to align with the world's most rigorous scientific evidence and better inform smokers that vaping is a less harmful alternative that can help them quit

BrandSafway Recognized with Two Project Awards from Scaffold Access and Industry Association (SAIA)

Top Specialty Contractor Wins Industry Recognition for Historic Contributions to Hangar One at Moffett Federal Airfield and US 181 Harbor Bridge, the Longest Cable-Stayed Bridge in the United States

Top Specialty Contractor Wins Industry Recognition for Historic Contributions to Hangar One at Moffett Federal Airfield and US 181 Harbor Bridge, the Longest Cable-Stayed Bridge in the United States

Nontuberculous Mycobacterial Infections Market to Showcase Growth at a CAGR of 12.6% During the Forecast Period (2026–2036), Driven by Rising Disease Burden and Emerging Therapies | DelveInsight

The nontuberculous mycobacterial infections Market is expected to experience notable growth in the coming years, driven by the increasing prevalence and improved diagnosis of NTM infections, particularly among aging populations and individuals with underlying respiratory conditions. Additionally, the expected launch of emerging therapies such as Omadacycline (NUZYRA; Paratek Pharmaceuticals), MRX-5 (MicuRx Pharmaceuticals), Epetraborole (AN2 Therapeutics), RHB-204 (Redhill Biopharma), and others will further propel market growth.

The nontuberculous mycobacterial infections Market is expected to experience notable growth in the coming years, driven by the increasing prevalence and improved diagnosis of NTM infections, particularly among aging populations and individuals with underlying respiratory conditions. Additionally, the expected launch of emerging therapies such as Omadacycline (NUZYRA; Paratek Pharmaceuticals), MRX-5 (MicuRx Pharmaceuticals), Epetraborole (AN2 Therapeutics), RHB-204 (Redhill Biopharma), and others will further propel market growth.

Volaris Group Acquires Biodiv-Wind

TORONTO, Aug. 31, 2026 (GLOBE NEWSWIRE) — Volaris Group (Volaris) today announced the acquisition of Biodiv-Wind SAS. Based in France, Biodiv-Wind is the market leader in real-time bird and bat detection systems for onshore wind farms. Its solutions, both hardware and software, are essential to regulatory compliance.

Schouw & Co. share buy-back programme, week 35 2026

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. As outlined in Company Announcement no. 48 of 14 August 2026, the programme was extended with up to DKK 170 million, increasing the total amount of which Schouw & Co. will acquire shares to up to DKK 410 million.

UMH PROPERTIES, INC. SECURES NEW FANNIE MAE MORTGAGE

FREEHOLD, NJ, Aug. 31, 2026 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE: UMH) (TASE: UMH) today announced that on August 28, 2026 it secured a new Fannie Mae mortgage for one of its communities containing 267 sites, through Wells Fargo Bank, N.A., for total proceeds of approximately $10.2 million. This interest-only loan is at a fixed rate of 6.03% with a 10-year term. Earlier this year, we paid off the existing $2.8 million mortgage on this community, generating $7.4 million in additional proceeds. The proceeds will be used to invest in additional acquisitions, expansions, rental homes and repay higher interest rate debt on a short-term basis.

UMH PROPERTIES, INC. SECURES NEW FANNIE MAE MORTGAGE

FREEHOLD, NJ, Aug. 31, 2026 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE: UMH) (TASE: UMH) today announced that on August 28, 2026 it secured a new Fannie Mae mortgage for one of its communities containing 267 sites, through Wells Fargo Bank, N.A., for total proceeds of approximately $10.2 million. This interest-only loan is at a fixed rate of 6.03% with a 10-year term. Earlier this year, we paid off the existing $2.8 million mortgage on this community, generating $7.4 million in additional proceeds. The proceeds will be used to invest in additional acquisitions, expansions, rental homes and repay higher interest rate debt on a short-term basis.

S-Pankki Oyj täydentää 16.7.2026 päivättyä tarjousasiakirjaa koskien tekemäänsä vapaaehtoista julkista käteisostotarjousta kaikista Oma Säästöpankki Oyj:n osakkeista

EI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI, KOKONAAN TAI OSITTAIN, SUORAAN TAI VÄLILLISESTI, AUSTRALIASSA, KANADASSA, HONGKONGISSA, JAPANISSA, UUDESSA-SEELANNISSA TAI ETELÄ-AFRIKASSA TAI NÄIHIN MAIHIN TAI MILLÄÄN MUULLA ALUEELLA TAI MILLEKÄÄN MUULLE ALUEELLE, JOSSA OSTOTARJOUS OLISI SOVELTUVAN LAIN VASTAINEN. LISÄTIETOJA ALLA KOHDASSA “TÄRKEÄÄ TIETOA”.